Literature DB >> 12230974

Single-stranded antisense siRNAs guide target RNA cleavage in RNAi.

Javier Martinez1, Agnieszka Patkaniowska, Henning Urlaub, Reinhard Lührmann, Thomas Tuschl.   

Abstract

Small interfering RNAs (siRNAs) are the mediators of mRNA degradation in the process of RNA interference (RNAi). Here, we describe a human biochemical system that recapitulates siRNA-mediated target RNA degradation. By using affinity-tagged siRNAs, we demonstrate that a single-stranded siRNA resides in the RNA-induced silencing complex (RISC) together with eIF2C1 and/or eIF2C2 (human GERp95) Argonaute proteins. RISC is rapidly formed in HeLa cell cytoplasmic extract supplemented with 21 nt siRNA duplexes, but also by adding single-stranded antisense RNAs, which range in size between 19 and 29 nucleotides. Single-stranded antisense siRNAs are also effectively silencing genes in HeLa cells, especially when 5'-phosphorylated, and expand the repertoire of RNA reagents suitable for gene targeting.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12230974     DOI: 10.1016/s0092-8674(02)00908-x

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  473 in total

1.  The microRNAs of Caenorhabditis elegans.

Authors:  Lee P Lim; Nelson C Lau; Earl G Weinstein; Aliaa Abdelhakim; Soraya Yekta; Matthew W Rhoades; Christopher B Burge; David P Bartel
Journal:  Genes Dev       Date:  2003-04-02       Impact factor: 11.361

2.  Similar behaviour of single-strand and double-strand siRNAs suggests they act through a common RNAi pathway.

Authors:  Torgeir Holen; Mohammed Amarzguioui; Eshrat Babaie; Hans Prydz
Journal:  Nucleic Acids Res       Date:  2003-05-01       Impact factor: 16.971

3.  siRNAs can function as miRNAs.

Authors:  John G Doench; Christian P Petersen; Phillip A Sharp
Journal:  Genes Dev       Date:  2003-02-15       Impact factor: 11.361

Review 4.  Developing therapeutic microRNAs for cancer.

Authors:  A G Bader; D Brown; J Stoudemire; P Lammers
Journal:  Gene Ther       Date:  2011-06-02       Impact factor: 5.250

Review 5.  miRNA profiling for biomarker discovery in multiple sclerosis: from microarray to deep sequencing.

Authors:  Mireia Guerau-de-Arellano; Hansjuerg Alder; Hatice Gulcin Ozer; Amy Lovett-Racke; Michael K Racke
Journal:  J Neuroimmunol       Date:  2011-11-09       Impact factor: 3.478

Review 6.  Review: placenta-specific microRNAs in exosomes - good things come in nano-packages.

Authors:  Y Ouyang; J-F Mouillet; C B Coyne; Y Sadovsky
Journal:  Placenta       Date:  2013-11-15       Impact factor: 3.481

Review 7.  RNA interference for glioblastoma therapy: Innovation ladder from the bench to clinical trials.

Authors:  Eunice L Lozada-Delgado; Nilmary Grafals-Ruiz; Pablo E Vivas-Mejía
Journal:  Life Sci       Date:  2017-08-31       Impact factor: 5.037

Review 8.  The use of nanoparticulates to treat breast cancer.

Authors:  Xiaomeng Tang; Welley S Loc; Cheng Dong; Gail L Matters; Peter J Butler; Mark Kester; Craig Meyers; Yixing Jiang; James H Adair
Journal:  Nanomedicine (Lond)       Date:  2017-09-04       Impact factor: 5.307

Review 9.  Regulation of translation initiation in eukaryotes: mechanisms and biological targets.

Authors:  Nahum Sonenberg; Alan G Hinnebusch
Journal:  Cell       Date:  2009-02-20       Impact factor: 41.582

10.  An approach to genomewide screens of expressed small interfering RNAs in mammalian cells.

Authors:  Lianxing Zheng; Jun Liu; Sergei Batalov; Demin Zhou; Anthony Orth; Sheng Ding; Peter G Schultz
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-19       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.